Latest Morpholines Stories
Multidistrict Litigation For Xarelto Bleeding Lawsuits That Allege Patients Experienced Uncontrollable Bleeding And Other Complications After Taking The Prescription Blood Thinner Has Been Established
The Firm is representing plaintiffs in Xarelto lawsuits that allege the blood thinner caused life-threatening internal bleeding, other serious complications. New
Maximum tolerated dose (MTD) identified and expansion cohort open to enrollment; Minimal Response (MR) or better has been observed in 25% of 8 patients treated to date at the MTD or higher
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition THOUSAND OAKS, Calif.
SAN FRANCISCO, Dec.
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND
- Final results from binimetinib Phase 2 in NRAS melanoma confirmed prior Progression Free Survival result and demonstrated encouraging Overall Survival- BOULDER, Colo., Nov.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable bleeding and other serious complications, allegedly due to their use of the blood thinner.
Defendant Xarelto manufacturers want several lawsuits dismissed from Pennsylvania state court, arguing that there is no connection with the state. Rockville
- The act of sweetening by admixture of some saccharine substance.